Oncology TabletsOncology tablets, such as TAGRISSO 80mg tablet and INTACEPT 50mg, are crucial in cancer treatment. TAGRISSO, containing osimertinib, is used for non-small cell lung cancer, targeting specific genetic mutations like EGFR-T790M. It inhibits cancer cell growth, extending survival rates and improving quality of life. INTACEPT, with the active ingredient etanercept, is utilized for conditions like rheumatoid arthritis and psoriasis, alleviating inflammation and symptoms. Benefits include tumor regression, pain relief, and improved joint function. Common side-effects of oncology tablets may include nausea, fatigue, and skin reactions. However, their potential benefits often outweigh these risks, offering hope and efficacy in cancer and autoimmune disease management.
|
|
MODERN TIMES HELP LINES PHARMA
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |